Cargando…
Hepatocellular carcinoma-targeted nanoparticles for cancer therapy
Nanocarriers, such as liposomes, have the potential to increase the payload of chemotherapeutic drugs while decreasing toxicity to non-target tissues; such advantageous properties can be further enhanced through surface conjugation of nanocarriers with targeting moieties. We previously reported that...
Autores principales: | Wu, Chien-Hsun, Lan, Chun-Hsin, Wu, Kuan-Lin, Wu, Yao-Ming, Jane, Wann-Neng, Hsiao, Michael, Wu, Han-Chung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741373/ https://www.ncbi.nlm.nih.gov/pubmed/29207071 http://dx.doi.org/10.3892/ijo.2017.4205 |
Ejemplares similares
-
Preclinical verification of the efficacy by targeting peptide-linked liposomal nanoparticles for hepatocellular carcinoma therapy
por: Wu, Cheng-Der, et al.
Publicado: (2019) -
Peptide-Mediated Liposomal Doxorubicin Enhances Drug Delivery Efficiency and Therapeutic Efficacy in Animal Models
por: Chang, De-Kuan, et al.
Publicado: (2013) -
Advances of Targeted Therapy for Hepatocellular Carcinoma
por: Niu, Mengke, et al.
Publicado: (2021) -
Targeted therapy or immunotherapy? Optimal treatment in hepatocellular carcinoma
por: Contratto, Merly, et al.
Publicado: (2018) -
Mesoporous Silica Nanoparticles for Potential Immunotherapy of Hepatocellular Carcinoma
por: Wu, Han, et al.
Publicado: (2021)